NEW
Font size
WorksheetsQuestion Set 1
Total questions: 10
Worksheet time: 3mins
Lung cancer is 2 nd common cancer in Vietnam. Please advise what is the number of new
patients acquired lung cancer per year in Vietnam according to GlobalCAN 2018?
23, 667
24, 667
25,667
Asia population have higher rate of EGFR Mutation Vs Western countries’. Please recall
how many percent of EGFR mutation in Asia lung cancer patients is?
10% - 20%
20% - 30%
40% - 60%
ALK is one of rare mutation in lung cancer. The percentage of ALK mutation in lung
cancer patients is?
1% - 3%
3% - 5%
5% - 7%
Alecensa (Alectinib) increases our belief about curable therapy in lung cancer. Please
share how long of PFS this brand offered to lung cancer, ALK (+)?
PFS > 33.8 months
PFS > 34.8 months
PFS > 36.8 months
Tecentriq (Atezolizumab) recovers natural body immune system to kill cancer cells
through PL-L1 pathway. Please recall what is the key benefit of Tecentriq in 2 nd line of
lung cancer treatment?
OS # 13.8 months
OS # 14.8 months
OS # 15.8 months
Tarceva (Erlotinib) was the first anti-EGFR therapy approved for the treatment of lung
cancer patients with EGFR MT. How long this brand offered the PFS to patients?
PFS # 12 months
PFS > 13 months
PFS 11 months
In the near future, Roche Vietnam would offer more effective therapies in lung cancer
patients including of:
2L Tecentriq, Alecensa, A + T (Avastin + Tarceva) and T + A (Tecentriq + Avastin)
1L Tecentriq, Alecensa, A + T and T plus A
Alecensa, A + T and T plus A
The most common kind of pathological histology of lung cancer is
Small cell carcinoma
Adenocarcinoma
Squamous cell carcinoma
Large cell carcinoma
Avastin (Bevacizumab) is an anti-angiogenesis therapy which approved to treat in lung
cancer in 2005. How long of OS this brand offered in lung cancer?
OS 24.3 months
OS 14.3 months
OS 24.0 months
How long of PFS A + T ( Avastin plus Tarceva) offered in lung cancer, EGFR (+)?
PFS 15.9 months
PFS 16.9 months
PFS 17.9 month
